Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Mangoceuticals, Inc. (MGRX)

0.2398 +0.0118 (+5.18%)
As of 9:44:39 AM EST. Market Open.
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
315.2270
456.0210
615.8730
731.4930
8.9390
Cost of Revenue
143.6370
205.6350
235.9090
299.9920
4.0890
Gross Profit
171.5900
250.3860
379.9640
431.5010
4.8500
Operating Expense
13,364.2600
19,405.3740
9,073.4900
9,650.3910
1,996.4320
Operating Income
-13,192.6700
-19,154.9880
-8,693.5260
-9,218.8900
-1,991.5820
Net Non Operating Interest Income Expense
-652.2190
-103.5130
-13.7000
0
-6.4730
Other Income Expense
--
-1,384.9540
--
6.4730
--
Pretax Income
-15,104.2180
-20,643.4550
-8,707.2260
-9,212.4170
-1,998.0550
Tax Provision
--
0
0
0
0
Net Income Common Stockholders
-16,279.5880
-21,818.9940
-9,508.2540
-9,212.4170
-1,998.0550
Diluted NI Available to Com Stockholders
-16,279.5880
-21,818.9940
-9,508.2540
-9,212.4170
-1,998.0550
Basic EPS
-1.00
-2.17
-4.80
-8.58
-1.96
Diluted EPS
-1.00
-2.17
-4.80
-8.58
-1.96
Basic Average Shares
14,831.3200
10,071.6090
1,978.9660
1,074.2020
1,021
Diluted Average Shares
14,831.3200
10,071.6090
1,978.9660
1,074.2020
1,021
Total Operating Income as Reported
-12,070.0310
-18,032.3490
-7,971.9930
-9,218.8900
-1,991.5820
Total Expenses
13,507.8970
19,611.0090
9,309.3990
9,950.3830
2,000.5210
Net Income from Continuing & Discontinued Operation
-15,103.5880
-20,642.9940
-8,706.1450
-9,212.4170
-1,998.0550
Normalized Income
-13,718.6340
-19,258.0400
-8,706.1450
-9,212.4170
-1,998.0550
Interest Expense
652.2190
103.5130
13.7000
0
6.4730
Net Interest Income
-652.2190
-103.5130
-13.7000
0
-6.4730
EBIT
-14,451.9990
-20,539.9420
-8,693.5260
-9,212.4170
-1,991.5820
EBITDA
-13,392.6080
-18,815.7390
-7,962.0570
-9,132.5490
-1,987.7190
Reconciled Cost of Revenue
143.6370
205.6350
225.9730
220.1240
4.0890
Reconciled Depreciation
1,059.3910
1,724.2030
731.4690
79.8680
3.8630
Net Income from Continuing Operation Net Minority Interest
-15,103.5880
-20,642.9940
-8,706.1450
-9,212.4170
-1,998.0550
Total Unusual Items Excluding Goodwill
-1,384.9540
-1,384.9540
0
--
--
Total Unusual Items
-1,384.9540
-1,384.9540
0
--
--
Normalized EBITDA
-12,007.6540
-17,430.7850
-7,962.0570
-9,132.5490
-1,987.7190
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 3/21/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: